Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) EBT Margin: 2010-2024

Historic EBT Margin for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to 8.77%.

  • Cryo Cell International's EBT Margin fell 19500.0% to 15.16% in Q3 2025 from the same period last year, while for Aug 2025 it was 4.57%, marking a year-over-year increase of 433500.0%. This contributed to the annual value of 8.77% for FY2024, which is 514100.0% up from last year.
  • Per Cryo Cell International's latest filing, its EBT Margin stood at 8.77% for FY2024, which was up 514100.0% from 42.64% recorded in FY2023.
  • In the past 5 years, Cryo Cell International's EBT Margin ranged from a high of 16.18% in FY2020 and a low of 42.64% during FY2023
  • Over the past 5 years, Cryo Cell International's median EBT Margin value was 9.04% (recorded in 2021), while the average stood at 0.46%.
  • In the last 5 years, Cryo Cell International's EBT Margin plummeted by -535800bps in 2023 and then skyrocketed by 514100bps in 2024.
  • Cryo Cell International's EBT Margin (Annual) stood at 16.18% in 2020, then crashed by -44bps to 9.04% in 2021, then increased by 21bps to 10.94% in 2022, then plummeted by -490bps to 42.64% in 2023, then surged by 121bps to 8.77% in 2024.
  • Its EBT Margin was 8.77% in FY2024, compared to 42.64% in FY2023 and 10.94% in FY2022.